Potassium Sulfate
CAS 7778-80-5
Potassium Sulfate (CAS 7778-80-5) is a Phase 4 pharmaceutical compound with 0 bioactivity targets and 24 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Product dose omission issue | 45 | 24.372 | 10084406 |
| Diarrhoea | 86 | 19.101 | 10012735 |
| Fatigue | 95 | 18.944 | 10016256 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| POTASSIUM SULFATE | 34323 | SU | MTHSPL |
| potassium sulfate | 34323 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Potassium Sulfate used for in pharmaceutical contexts?
Potassium Sulfate (CAS 7778-80-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Potassium Sulfate?
Potassium Sulfate has 24 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Product dose omission issue, Diarrhoea, Fatigue, Abdominal pain, Abdominal pain upper. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Potassium Sulfate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Potassium Sulfate with EU status "permitted".
What clinical phase is Potassium Sulfate in?
Potassium Sulfate is rendered with ChEMBL max phase 4 (approved).